Fig. 3
From: A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
NIAID 8-point ordinal scale was used for the patient inclusion criteria and treatment endpoint in ACCT-2 study. NIAID 8-point ordinal scale was used for the patient inclusion criteria and treatment endpoint. Patients assigned as level 4 (hospitalized but not requiring oxygen supplementation; requiring continuous therapy) to level 7 (hospitalized and managed by invasive mechanical ventilation or ECMO) were included. The primary outcome was clinical improvement to level 1 (not hospitalized or restricting activities) to level 3 (hospitalized but not requiring oxygen supplementation; not requiring continuous therapy) on days 14 by the treatments